Every recall we track for Noven Pharmaceuticals Inc — 51 in all — plus the complaints and injury reports the public filed about them.
Noven Pharmaceuticals recalls Daytrana 20mg transdermal patches due to defective delivery system causing out-of-specification shear. Affected lots expire 7/2023 to 10/2023.
Noven Pharmaceuticals recalls Daytrana 15mg transdermal patches due to defective delivery system. Learn if your product is affected and what to do.
Noven Pharmaceuticals recalls Daytrana 10mg transdermal patches due to defective delivery system. This may cause inconsistent drug release. Check NDC 68968-5552-3 and lot numbers 91955 or 93039 for affected products.
Noven Pharmaceuticals recalls Daytrana (methylphenidate transdermal system) 30mg 30-count cartons with defective delivery system. Affected lots expire 3/2023 to 10/2023. Stop using immediately if you have these products.
Noven Pharmaceuticals recalls Daytrana patches (15mg over 9 hours) with defective adhesive that may not deliver medication properly. Affected lots were manufactured in Miami, FL, with expiration 02/2023.
Noven Pharmaceuticals recalls Daytrana patches due to defective delivery system causing customer complaints exceeding action limits. This medication is prescription-only and contains 30 patches.
Noven Pharmaceuticals recalls specific Combipatch hormone patches due to stability issues. These patches may not function correctly, potentially affecting hormone levels. Consumers should check product details and contact Noven for guidance.
Noven Pharmaceuticals recalls specific Combipatch hormone patches due to stability issues. These patches may not function correctly over time, potentially affecting hormone levels. Stop using and contact for details.
Noven Pharmaceuticals recalls Daytrana patches (NDC 68968-5553-1) due to customer complaints about ripping and adhesive transfer problems. This may affect proper medication delivery.
Noven Pharmaceuticals recalls Daytrana patches (NDC 68968-5552-1) after customer complaints about patches ripping and adhesive transfer problems. This affects prescription medication for ADHD.
